Results 11 to 20 of about 289,464 (193)

Preliminary Cost-Effectiveness and Cost-Utility Analysis of Cemiplimab in Patients with Advanced Cutaneous Squamous Cell Carcinoma in Italy

ClinicoEconomics and Outcomes Research, 2021
Gianni Ghetti,1 Maria Claudia D’Avella,2 Lorenzo Pradelli1 1Department of Health Economics and Outcome Research, AdRes, Turin, Italy; 2Department of Market Access, Sanofi, Milan, ItalyCorrespondence: Gianni GhettiDepartment of Health Economics and ...
Ghetti G, D'Avella MC, Pradelli L
doaj  

Costo-utilità di dalbavancina versus standard of care (SoC) in pazienti con ABSSSI non severa in Italia

Global & Regional Health Technology Assessment, 2020
Introduction: Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) include all complicated skin and soft tissue infections. The aim of this study was to conduct a cost-utility analysis to compare dalbavancin with standard antibiotic therapies for
Andrea Marcellusi, Chiara Bini, Maria Assunta Rotundo, Rosario Cultrera, Francesco Saverio Mennini   +4 more
doaj   +1 more source

Rituximab for the treatment of relapsing-remitting multiple sclerosis in Thailand: an economic evaluation and budget impact analysis

BMC Health Services Research, 2023
Background Multiple sclerosis is an inflammatory demyelination process in the central nervous system (CNS) causing neurological disability and poor quality of life.
Saharat Aungsumart, Saowalak Turongkaravee, Sitaporn Youngkong, Metha Apiwattanakul, Ammarin Thakkinstian, Usa Chaikledkaew   +5 more
doaj   +1 more source

A Comparison of Cost-Benefit and Cost-Effectiveness Analysis in Practice: Divergent Policy Practices in Sweden

Nordic Journal of Health Economics, 2017
This paper compares the implementation of the two economic evaluation methods Cost-Effectiveness/Utility (CEA/CUA) and Cost-Benefit Analysis (CBA) as tools for allocation of national public funds in the health and transport sector in Sweden, respectively.
Mikael Svensson, Lars Hultkrantz
doaj   +1 more source

Should we use Palivizumab immunoprophylaxis for infants against respiratory syncytial virus? – a cost-utility analysis

Israel Journal of Health Policy Research, 2018
Background Passive immunization against RSV (Respiratory Syncytial Virus) is given in most western countries (including Israel) to infants of high risk groups such as premature babies, and infants with Congenital Heart Disease or Congenital Lung Disease.
Gary M. Ginsberg, Eli Somekh, Yechiel Schlesinger   +2 more
doaj   +1 more source

Cost-Utility Analysis of Open Hernia Operations in Bulgaria

Acta Medica Bulgarica, 2022
Background: Hernia surgery procedures are among the most frequently performed in Bulgaria. An open, mesh-based repair is a standard method for hernia repair.
Kirilova-Doneva M., Kamusheva M., Gerasimov N., Petrova G.   +3 more
doaj   +1 more source

Economic Evaluation of Health Interventions: A Critical Review

Iranian Journal of Public Health, 2022
Background: Economic evaluation is used for the optimal allocation of resources in the health sector. While a large number of economic evaluation studies have been conducted, there is less critical review of these studies.
Ali Mohammad Mosadeghrad, Ebrahim Jaafaripooyan, Mahmoud Zamandi   +2 more
doaj  

Cost-utility analysis of bariatric surgery compared with conventional medical management in Germany: a decision analytic modeling

BMC Surgery, 2017
Background The objective was to evaluate cost-utility of bariatric surgery in Germany for a lifetime and 10-year horizon from a health care payer perspective.
Oleg Borisenko, Oliver Mann, Anna Duprée   +2 more
doaj   +1 more source

Medico-economic impact of thoracoscopy versus thoracotomy in lung cancer: multicentre randomised controlled trial (Lungsco01)

BMC Health Services Research, 2023
Background Lungsco01 is the first study assessing the real benefits and the medico-economic impact of video-thoracoscopy versus open thoracotomy for non-small cell lung cancer in the French context.
Anne-Laure Soilly, Ludwig Serge Aho Glélé, Alain Bernard, Halim Abou Hanna, Marc Filaire, Pierre Magdaleinat, Charles Marty-Ané, François Tronc, Renaud Grima, Jean-Marc Baste, Pascal-Alexandre Thomas, Bertrand Richard De Latour, Arnaud Pforr, Pierre-Benoît Pagès   +13 more
doaj   +1 more source

An Introduction to the Main Types of Economic Evaluations Used for Informing Priority Setting and Resource Allocation in Healthcare: Key Features, Uses, and Limitations

Frontiers in Public Health, 2021
Economic evidence is increasingly being used for informing health policies. However, the underlining principles of health economic analyses are not always fully understood by non-health economists, and inappropriate types of analyses, as well as ...
Hugo C. Turner, Rachel A. Archer, Laura E. Downey, Wanrudee Isaranuwatchai, Wanrudee Isaranuwatchai, Kalipso Chalkidou, Mark Jit, Mark Jit, Yot Teerawattananon, Yot Teerawattananon   +9 more
doaj   +1 more source